Sutro Biopharma (STRO) stock surged +67% over the last 30 days, driven by positive preclinical data presentations and ongoing clinical advancements in its antibody drug conjugate (ADC) pipeline. Over the past quarter, shares climbed +119%, fueled by a $110 million public offering, full-year 2025 earnings release highlighting strong cash position, and key trial initiations.

Wolfspeed (WOLF) stock surged +59% over the past 30 days, driven by optimism in the semiconductor sector and post-bankruptcy recovery momentum. Over the past quarter, shares rose +35%, reflecting sustained interest despite earnings misses, bolstered by debt restructuring and strategic equity issuance.

SLNO stock surged +66% over the past 30 days, primarily fueled by Neurocrine Biosciences' ( NBIX ) announcement of a $2.9 billion all-cash acquisition at $53 per share. The stock rose +20% over the past quarter, recovering from mid-March lows amid positive earnings and product launch momentum before the buyout catalyst.

BlackBerry Limited (BB) stock surged +70% over the past 30 days, driven by a strong Q4 earnings beat and a major partnership with Nvidia for QNX integration. Over the past quarter, shares rose +45%, reflecting improved revenue from QNX embedded software and secure communications segments amid a company turnaround.

NEXA stock surged +67% over the last 30 days amid analyst upgrades, reserve expansions, and strong trading volume, marking a volatile but upward trend. Over the past quarter, shares rose +23%, recovering from a mid-period dip driven by operational updates and favorable metal prices.

Target Hospitality (TH) stock surged +63% over the past 30 days, primarily driven by a landmark $550 million multi-year contract for data center workforce housing. The stock rose +104% over the past quarter, fueled by strong Q4 2025 earnings with revenue beats, raised 2026 guidance, and expanding contracts in high-demand sectors.

Jade Biosciences (JBIO) stock surged +69% over the last 30 days, driven by heightened trading volume and positive biotech sector sentiment. Over the past quarter, shares rose +47%, reflecting broader recovery and anticipation around pipeline progress.

AOSL stock surged +76% over the past 30 days, driven by semiconductor sector momentum and growing demand for power semiconductors in AI datacenters. Over the past quarter, shares rose +74%, reflecting recovery from post-earnings volatility and a strategic pivot toward high-value markets.

MXL stock surged +88% over the last 30 days, fueled by analyst price target increases and building momentum ahead of quarterly earnings. Over the past quarter, shares climbed +67%, reflecting recovery from earlier lows driven by robust Q4 revenue growth in infrastructure and data centers.

LWLG stock surged approximately +110% over the last 30 days, driven primarily by momentum from a key partnership announcement and heightened investor interest in AI-related photonics technologies. Over the past quarter, the stock rose about +225%, fueled by commercial pipeline updates, design wins, and a major development agreement with a semiconductor foundry.

SOXL surged +78% over the past 30 days, driven by a powerful rally in the semiconductor sector fueled by AI chip demand. The ETF gained +49% over the past quarter, reflecting sustained strength in top holdings like NVIDIA and Broadcom amid robust earnings.

Defiance Quantum ETF (QTUM) surged +18% over the past 30 days, driven by strong performance in AI-related semiconductors and quantum computing enthusiasm. Over the past quarter, QTUM gained +10%, reflecting sustained interest in machine learning and quantum technologies amid broader tech sector strength.

FTXL surged +26% over the past 30 days, driven by robust demand for AI-related semiconductors and strong gains in top holdings like Broadcom and NVIDIA. The ETF gained +28% over the past quarter, reflecting sustained sector momentum amid AI infrastructure buildout and improving chip sales.

XSD surged +25% over the past 30 days, driven by robust demand for AI chips and strong earnings from key semiconductor players. The ETF climbed +17% over the past quarter, reflecting sustained sector momentum amid AI infrastructure buildout.

The iShares Semiconductor ETF (SOXX) surged +25% over the past 30 days, propelled by robust demand for AI chips and strong earnings from top holdings like NVIDIA ( NVDA ) and Broadcom ( AVGO ). Over the past quarter, SOXX gained +24%, reflecting sustained semiconductor sector strength amid broader technology market trends.

VanEck Semiconductor ETF (SMH) surged +20% over the past 30 days, propelled by robust demand for AI chips and strong performances from top holdings like NVIDIA and Taiwan Semiconductor. Over the past quarter, SMH gained +15%, reflecting a volatile path with a late-March dip followed by a sharp April rebound amid ongoing AI enthusiasm.

QXO shares fell approximately 8% on Monday, April 21, 2026, as markets reacted negatively to the company's announcement of a $17 billion acquisition of TopBuild Corp. (BLD), its second major deal in under 12 months. The acquisition, announced on April 19, 2026, values TopBuild at $505 per share — a 23% premium to its April 17 closing price — and will be partially financed through new equity issuance, raising investor concerns about significant dilution.

AXTI shares are falling approximately 10% on Monday, April 21, 2026, pulling from the April 17 closing price of $82.56 to around $74.30, extending a pattern of extreme volatility that has characterized the stock throughout April. No single major new fundamental catalyst has emerged today; the decline reflects a continued valuation reset following a staggering multi-month rally driven by AI-related indium phosphide demand expectations.

CLF shares declined approximately 8% on Monday, April 21, 2026, despite reporting Q1 2026 results that beat both earnings and revenue consensus estimates. The selloff was driven by a deeply disappointing Adjusted EBITDA of just $95 million for the quarter — far below investor expectations — after an $80 million one-time energy cost hit caused by extreme cold weather events.

AGIO shares fell approximately 20% in Monday's trading session, from a prior close of $35.14 on April 17, 2026, to approximately $28.11, representing one of the stock's largest single-session declines in months. The selloff coincides with the April 20, 2026, lead plaintiff deadline in a securities class-action lawsuit filed against the company, alleging potential violations of securities laws tied to disclosures surrounding Pyrukynd's clinical and regulatory development.